Priority Date: 20.06.16 (US 201662352087P)

USE OF CYCLIC PHOSPHATE SUBSTITUTED NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF VIRAL DISEASES

  • Application ID: EP17816018
  • Status: █ Request for examination was made

Applicant

Technology company logo small
Merck & Co. Inc.
Technology Company

Attorneys

no data provided

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). There is no patent agent firm in the market, which is specialized in this combination of IPC classes.

Timeline

  • 20.06.2016 - Priority Date (US 201662352087P)
  • 28.12.2017 - Publication A1 (WO2017223024)
  • 24.04.2019 - Publication A1 (EP3471739)